Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Details | |
|---|---|---|---|---|
Loxo Oncology, Inc.Listing unverified | Buy | $5M | SEC | |
Aravive, Inc.Listing unverified | Buy | $2.5M | SEC | |
AGILE THERAPEUTICS INCListing unverified | Buy | $4.8M | SEC | |
Aravive, Inc.Listing unverified | OtherD (derivative) | — | SEC | |
Aravive, Inc.Listing unverified | OtherD (derivative) | — | SEC | |
Aravive, Inc.Listing unverified | Other | — | SEC | |
Aravive, Inc.Listing unverified | OtherD (derivative) | — | SEC | |
Aravive, Inc.Listing unverified | Buy | $1.3M | SEC | |
Aravive, Inc.Listing unverified | Other | — | SEC | |
Aravive, Inc.Listing unverified | OtherD (derivative) | — | SEC | |
Aravive, Inc.Listing unverified | Other | — | SEC | |
Aravive, Inc.Listing unverified | Other | — | SEC | |
Aravive, Inc.Listing unverified | Other | — | SEC | |
Aravive, Inc.Listing unverified | OtherD (derivative) | — | SEC | |
Zeltiq Aesthetics IncListing unverified | Sell | $7M | SEC |